<--- Back to Details
First PageDocument Content
Organic chemistry / Vecuronium bromide / Atracurium besilate / Tubocurarine chloride / Neuromuscular-blocking drug / Pharmaceutical drug / Mivacurium chloride / Suxamethonium chloride / Pharmacy / Chemistry / Muscle relaxants / Quaternary ammonium compounds
Date: 2009-08-07 11:27:34
Organic chemistry
Vecuronium bromide
Atracurium besilate
Tubocurarine chloride
Neuromuscular-blocking drug
Pharmaceutical drug
Mivacurium chloride
Suxamethonium chloride
Pharmacy
Chemistry
Muscle relaxants
Quaternary ammonium compounds

ISMP Canada where NMBA medication incidents occur, they can provide valuable lessons for enhancing NMBA safety. The following cases are provided to increase awareness of potential systembased failures.

Add to Reading List

Source URL: www.ismp-canada.org

Download Document from Source Website

File Size: 173,63 KB

Share Document on Facebook

Similar Documents

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

Send Orders of Reprints at  614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets

Send Orders of Reprints at 614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets

DocID: 1v1vA - View Document

eclipse | RBM data sheet  Risk Based Monitoring (RBM) Drug costs are soaring. The pharmaceutical, biotech and CRO industries are more competitive than ever before. Companies like yours are looking for ways to reduce expe

eclipse | RBM data sheet Risk Based Monitoring (RBM) Drug costs are soaring. The pharmaceutical, biotech and CRO industries are more competitive than ever before. Companies like yours are looking for ways to reduce expe

DocID: 1uZyk - View Document

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

DocID: 1utU5 - View Document

AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card Issued by the ATAC Drug Development Committee September 10, 2009

AIDS Treatment Activists Coalition (ATAC) Pharmaceutical Company HIV/AIDS Report Card Issued by the ATAC Drug Development Committee September 10, 2009

DocID: 1u8Vg - View Document